FDA Conflict Of Interest Policies Will Be Reviewed By House Committee
This article was originally published in The Pink Sheet Daily
Executive Summary
Energy & Commerce Committee wants copies of all approved and rejected consulting requests since 1999. FDA is one of 15 agencies to receive the request as the committee looks beyond NIH.
You may also be interested in...
NIH Disclosure Of Outside Activities Differs From Pfizer Report, House Cmte. Finds
House Commerce Committee identifies 100 instances where drug companies reported consulting arrangements and the National Institutes of Health did not disclose those arrangements. In an effort to place "NIH ethics issues in context," the committee is requesting FDA and 14 other agencies submit lists of outside compensation.
NIH Disclosure Of Outside Activities Differs From Pfizer Report, House Cmte. Finds
House Commerce Committee identifies 100 instances where drug companies reported consulting arrangements and the National Institutes of Health did not disclose those arrangements. In an effort to place "NIH ethics issues in context," the committee is requesting FDA and 14 other agencies submit lists of outside compensation.
FDA Employees’ Outside Activities Will Receive Scrutiny By Center Directors
Activities had been approved at lower levels, but the interim policy – issued following questions about behavior of NIH scientists – escalates the oversight. All outside activities by FDA employees will be reviewed as part of the development of a final policy.